205 related articles for article (PubMed ID: 21297554)
1. Rapamycin impairs proliferation of transplanted islet β cells.
Niclauss N; Bosco D; Morel P; Giovannoni L; Berney T; Parnaud G
Transplantation; 2011 Apr; 91(7):714-22. PubMed ID: 21297554
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function.
Zhang N; Su D; Qu S; Tse T; Bottino R; Balamurugan AN; Xu J; Bromberg JS; Dong HH
Diabetes; 2006 Sep; 55(9):2429-36. PubMed ID: 16936190
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin impairs in vivo proliferation of islet beta-cells.
Zahr E; Molano RD; Pileggi A; Ichii H; Jose SS; Bocca N; An W; Gonzalez-Quintana J; Fraker C; Ricordi C; Inverardi L
Transplantation; 2007 Dec; 84(12):1576-83. PubMed ID: 18165767
[TBL] [Abstract][Full Text] [Related]
4. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.
Johnson JD; Ao Z; Ao P; Li H; Dai LJ; He Z; Tee M; Potter KJ; Klimek AM; Meloche RM; Thompson DM; Verchere CB; Warnock GL
Cell Transplant; 2009; 18(8):833-45. PubMed ID: 19500470
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin induces autophagy in islets: relevance in islet transplantation.
Tanemura M; Saga A; Kawamoto K; Machida T; Deguchi T; Nishida T; Sawa Y; Doki Y; Mori M; Ito T
Transplant Proc; 2009; 41(1):334-8. PubMed ID: 19249550
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies.
Fabian MC; Lakey JR; Rajotte RV; Kneteman NM
Transplantation; 1993 Nov; 56(5):1137-42. PubMed ID: 8249114
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin impairs beta-cell proliferation in vivo.
Zahr E; Molano RD; Pileggi A; Ichii H; San Jose S; Bocca N; An W; Gonzalez-Quintana J; Fraker C; Ricordi C; Inverardi L
Transplant Proc; 2008 Mar; 40(2):436-7. PubMed ID: 18374093
[TBL] [Abstract][Full Text] [Related]
8. GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone.
Prud'homme GJ; Glinka Y; Hasilo C; Paraskevas S; Li X; Wang Q
Transplantation; 2013 Oct; 96(7):616-23. PubMed ID: 23851932
[TBL] [Abstract][Full Text] [Related]
9. Nerve Growth Factor Improves Survival and Function of Transplanted Islets Via TrkA-mediated β Cell Proliferation and Revascularization.
Hata T; Sakata N; Yoshimatsu G; Tsuchiya H; Fukase M; Ishida M; Aoki T; Katayose Y; Egawa S; Unno M
Transplantation; 2015 Jun; 99(6):1132-43. PubMed ID: 25806408
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cells.
Aronovitz A; Josefson J; Fisher A; Newman M; Hughes E; Chen F; Moons DS; Kiyokawa H; Lowe WL
J Investig Med; 2008 Dec; 56(8):985-96. PubMed ID: 19105244
[TBL] [Abstract][Full Text] [Related]
11. Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets.
Cantaluppi V; Biancone L; Figliolini F; Beltramo S; Medica D; Deregibus MC; Galimi F; Romagnoli R; Salizzoni M; Tetta C; Segoloni GP; Camussi G
Cell Transplant; 2012; 21(6):1305-20. PubMed ID: 22455973
[TBL] [Abstract][Full Text] [Related]
12. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
[TBL] [Abstract][Full Text] [Related]
13. Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy.
Soleimanpour SA; Hirshberg B; Bunnell DJ; Sumner AE; Ader M; Remaley AT; Rother KI; Rickels MR; Harlan DM
Cell Transplant; 2012; 21(6):1297-304. PubMed ID: 22080915
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs.
Cross SE; Richards SK; Clark A; Benest AV; Bates DO; Mathieson PW; Johnson PR; Harper SJ; Smith RM
Diabetologia; 2007 Jul; 50(7):1423-32. PubMed ID: 17476476
[TBL] [Abstract][Full Text] [Related]
15. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
16. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients.
Kneteman NM; Lakey JR; Wagner T; Finegood D
Transplantation; 1996 Apr; 61(8):1206-10. PubMed ID: 8610419
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of mycophenolic acid on survival, function, and gene expression of pancreatic beta-cells.
Gallo R; Natale M; Vendrame F; Boggi U; Filipponi F; Marchetti P; Laghi Pasini F; Dotta F
Acta Diabetol; 2012 Dec; 49 Suppl 1():S123-31. PubMed ID: 22249339
[TBL] [Abstract][Full Text] [Related]
18. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories.
Hyder A; Laue C; Schrezenmeir J
Toxicol In Vitro; 2005 Jun; 19(4):541-6. PubMed ID: 15826812
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin in islet transplantation: friend or foe?
Berney T; Secchi A
Transpl Int; 2009 Feb; 22(2):153-61. PubMed ID: 18713146
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable.
Dai C; Walker JT; Shostak A; Padgett A; Spears E; Wisniewski S; Poffenberger G; Aramandla R; Dean ED; Prasad N; Levy SE; Greiner DL; Shultz LD; Bottino R; Powers AC
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31941840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
